Company research / UFPT

UFP Technologies Inc (UFPT)

SEC name UFP TECHNOLOGIES INC · CIK 0000914156 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, UFP Technologies Inc reported revenue of $602.80M. Revenue grew 19.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $631.64M.

Key ratios (year ended 2025-12-31)

28.3%
Gross margin
15.3%
Operating margin
11.3%
Net margin
16.1%
Return on year-end equity
19.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-08-27

Headquarters locality: Georgetown · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$631.64M$602.80M$504.42M$400.07M$353.79M$206.32M$179.37M$198.38M$190.46M$147.84M$146.13M
Cost of Revenue$451.64M$432.39M$357.73M$287.85M$263.53M$155.21M$134.69M$144.42M$142.15M$112.36M$111.48M
Gross Profit$180.00M$170.41M$146.69M$112.22M$90.26M$51.11M$44.68M$53.96M$48.31M$35.49M$34.65M
R&D Expensen/a$8.60M$10.40M$7.20M$9.30M$8.50M$8.20M$8.80M$10.50M$5.00M$1.30M
Operating Income$96.35M$92.34M$80.90M$57.66M$55.40M$21.22M$16.73M$24.71M$19.61M$11.69M$12.24M
Depreciation & Amortizationn/a$19.15M$14.71M$11.41M$11.89M$8.41M$8.27M$8.17M$7.83M$5.63M$5.63M
EBITDAn/a$111.49M$95.61M$69.07M$67.29M$29.63M$25.00M$32.88M$27.44M$17.33M$17.87M
Net Income$72.30M$68.31M$58.98M$44.92M$41.79M$15.89M$13.37M$19.75M$14.31M$9.21M$7.97M
EPS (Diluted)n/a$8.75$7.58$5.83$5.45$2.09$1.77$2.63$1.93$1.26$1.10
Total Assets$681.91M$655.08M$629.00M$404.14M$378.19M$334.13M$203.20M$188.76M$189.60M$138.21M$127.93M
Total Liabilities$219.48M$231.20M$286.24M$118.05M$140.65M$139.69M$26.31M$26.77M$49.14M$14.49M$14.88M
Long-Term Debt$117.31M$135.46M$189.38M$32.00M$55.00M$75.00Mn/an/a$25.14Mn/a$856.0K
Shareholders' Equity$462.43M$423.88M$342.76M$286.09M$237.54M$194.45M$176.89M$161.99M$140.46M$123.71M$113.05M
Cash & Equivalents$9.04M$20.30M$13.45M$5.26M$4.45M$11.12M$24.23M$3.74M$3.24M$37.98M$31.36M
Operating Cash Flow$71.58M$91.91M$66.59M$41.33M$17.74M$14.29M$25.04M$31.23M$21.32M$17.47M$9.31M
Capital Expendituresn/an/a$9.66M$10.49M$13.78M$5.39M$4.37M$5.78M$5.43M$10.38M$7.21M
Free Cash Flown/an/a$56.94M$30.84M$3.96M$8.90M$20.67M$25.45M$15.89M$7.09M$2.10M
Shares Outstanding7.75M7.71M7.68M7.64M7.64M7.58M7.50M7.45M7.39M7.28M7.21M
Weighted Average Diluted Sharesn/a7.80M7.79M7.70M7.66M7.62M7.57M7.52M7.43M7.34M7.28M
EPS (Basic)n/a$8.87$7.69$5.89$5.52$2.11$1.79$2.66$1.95$1.27$1.11

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView